CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,162 | +29.7% | 616,478 | +43.6% | 0.06% | +30.2% |
| Q2 2023 | $14,001 | -29.6% | 429,219 | -24.0% | 0.04% | -37.7% |
| Q1 2023 | $19,874 | -27.7% | 564,752 | -5.8% | 0.07% | -29.6% |
| Q4 2022 | $27,471 | -99.9% | 599,542 | -4.7% | 0.10% | -18.3% |
| Q3 2022 | $30,465,000 | +18.6% | 628,799 | -3.8% | 0.12% | +22.4% |
| Q2 2022 | $25,677,000 | -12.1% | 653,513 | -17.6% | 0.10% | -3.9% |
| Q1 2022 | $29,196,000 | -23.8% | 793,156 | -5.6% | 0.10% | -20.3% |
| Q4 2021 | $38,315,000 | +30.5% | 840,601 | +2.3% | 0.13% | +17.4% |
| Q3 2021 | $29,369,000 | +35.4% | 821,747 | -25.0% | 0.11% | +41.6% |
| Q2 2021 | $21,686,000 | +2.8% | 1,095,804 | +20.9% | 0.08% | -11.5% |
| Q1 2021 | $21,090,000 | +59.8% | 906,722 | +42.8% | 0.09% | +42.6% |
| Q4 2020 | $13,197,000 | – | 635,086 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |